Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Malignant Melanoma

  Free Subscription


2 Ann Surg Oncol
1 BMC Cancer
1 Br J Dermatol
1 Cancer Lett
3 Cancer Res
1 Clin Cancer Res
1 Eur J Dermatol
1 J Invest Dermatol
1 J Surg Oncol
1 N Engl J Med
1 Ophthalmology
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. MIURA JT, Kroon HM, Beasley GM, Mullen D, et al
    Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Ann Surg Oncol. 2019 Mar 25. pii: 10.1245/s10434-019-07288.
    PubMed     Text format     Abstract available

  2. NIJHUIS AAG, Dieng M, Khanna N, Lord SJ, et al
    False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
    Ann Surg Oncol. 2019 Mar 25. pii: 10.1245/s10434-019-07311.
    PubMed     Text format     Abstract available

    BMC Cancer

  3. BLAIR CM, Walsh NM, Littman BH, Marcoux FW, et al
    Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-Raf.
    BMC Cancer. 2019;19:266.
    PubMed     Text format     Abstract available

    Br J Dermatol

  4. ELIAS ML, Lambert WC
    Surgical Management of Localized Melanoma: A National Cancer Database Retrospective Review.
    Br J Dermatol. 2019 Mar 25. doi: 10.1111/bjd.17901.
    PubMed     Text format     Abstract available

    Cancer Lett

  5. CHEN Y, Sumardika IW, Tomonobu N, Winarsa Ruma IM, et al
    Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Cancer Lett. 2019 Mar 20. pii: S0304-3835(19)30179.
    PubMed     Text format     Abstract available

    Cancer Res

  6. SHURIN GV, Kruglov O, Ding F, Lin Y, et al
    Melanoma-induced reprogramming of Schwann cell signaling aids tumor growth.
    Cancer Res. 2019 Mar 26. pii: 0008-5472.CAN-18-3872.
    PubMed     Text format     Abstract available

  7. REVACH OY, Sandler O, Samuels Y, Geiger B, et al
    Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells.
    Cancer Res. 2019 Mar 26. pii: 0008-5472.CAN-18-2316.
    PubMed     Text format     Abstract available

  8. KIM E, Zucconi BE, Wu M, Nocco SE, et al
    MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.
    Cancer Res. 2019 Mar 25. pii: 0008-5472.CAN-18-2331.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  9. WEISS SA, Wolchok JD, Sznol M
    Immunotherapy of melanoma: facts and hopes.
    Clin Cancer Res. 2019 Mar 28. pii: 1078-0432.CCR-18-1550.
    PubMed     Text format     Abstract available

    Eur J Dermatol

  10. YOKOTA K, Matsumoto T, Urata T, Goto K, et al
    The benefits of high-resolution, real-time colour-imaging of lymphatic flow for sentinel lymph node biopsy.
    Eur J Dermatol. 2018;28:680-681.
    PubMed     Text format    

    J Invest Dermatol

  11. SANA G, Madigan JP, Gartner JJ, Fourrez M, et al
    Exome sequencing of ABCB5 identifies recurrent melanoma mutations that result in increased proliferative and invasive capacities.
    J Invest Dermatol. 2019 Mar 21. pii: S0022-202X(19)31330.
    PubMed     Text format     Abstract available

    J Surg Oncol

    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 24. doi: 10.1002/jso.25442.
    PubMed     Text format    

    N Engl J Med

  13. PIANA S, Longo C
    Diffuse Melanosis and Melanuria.
    N Engl J Med. 2019;380:1166.
    PubMed     Text format    


    Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis.
    Ophthalmology. 2019;126:483-487.
    PubMed     Text format    

    PLoS One

  15. AZIZOVA TV, Bannikova MV, Grigoryeva ES, Rybkina VL, et al
    Risk of malignant skin neoplasms in a cohort of workers occupationally exposed to ionizing radiation at low dose rates.
    PLoS One. 2018;13:e0205060.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  16. MIROSHNICHENKO SK, Patutina OA, Burakova EA, Chelobanov BP, et al
    Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties.
    Proc Natl Acad Sci U S A. 2019;116:1229-1234.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.